Investors Back Up

You are here:

Home
Investors Back Up

For Investors

Media Release On Vitamin C Launch	Intimation Under Reg 30 Of Sebi (Lodr)
Board Of Directors	Code Of Conduct
Investor Information	Terms And Condition Of Appointment Of Independent Director
Notice Regarding Change Of Rta.	Press Release
Press Release — Launches Vaginal Spray	Press Release On Ndds Formulation Ondansetron Oral Spray (Domi Up)
A.G.M.-2016 Scrutinizer Report	Agm-2017 Scrutinizer Report
Press Release For Awardwd Patent Antimalarial Drug.	Details Of Nodal Officer Under Iepf
Appointment Of Director On The Board Of The Company	Intimation Of Regulation 30 Of Sebi, Lodr
Dematerialization Of Physical Securities	A.G.M. – 2018 – Scrutinizer Report
Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information	A.G.M. -2019 Scrutinizer Report
Press Release On Patent	Change In Officials Of Determining The Materiality Of Events
Media Release On Eu Gmp	Disclousre On Material Impact Of Covid-19
Media Release On Vitamin C Launch	Intimation Under Reg 30 Of Sebi (Lodr)

Annual Report

Annual Report 2009-2010	Annual Report 2010-2011	Annual Report 2011-2012
Annual Report 2012-2013	Annual Report 2013-2014	EGM Notice-LPL
E.G.M. SCRUTINIZER’S REPORT	Annual Report 2014-2015	AGM-2015 Notice
SCRUTINIZER’S REPORT A.G.M.-2015	Annual Report 2015-2016	AGM 2015-2016 Notice
Annual Report 2016-2017	AGM 2016-2017 Notice	Annual Report 2017-2018
AGM-2018 Notice	Annual Report 2018-2019	AGM-2019 Notice
Annual Report 2019-2020	AGM-2020 Notice	Scrutinizer & Evoting Report-AGM 2020
AGM Transcript 2019-20	Annual Report 2020-2021	Notice 2020-21 LPL
AGM Transcript 2020-2021	Final MGT – 7 2020-2021	AGM NOTICE 2021-22
Annual Report 2021-2022	Final MGT – 7 2021-2022	AGM Transcript 2021-2022
Scrutinizer and E-voting Report AGM 2022

Share Holding Pattern

Quarter ended Mar’11	Quarter ended Jun’11	Quarter ended Sep’11
Quarter ended Dec’11	Quarter ended Mar’12	Quarter ended Jun’12
Quarter ended Sep’12	Quarter ended Dec’12	Quarter ended Mar’13
Quarter ended June’13	Quarter ended Sep’13	Quarter ended Dec’13
Quarter ended Mar’14	Quarter ended Jun’14	Quarter ended Sep’14
Quarter ended Dec’14	Quarter ended Mar’15	Quarter ended Jun’15
Quarter ended Sep’15	Quarter ended Dec’15	Quarter ended Mar’16
Quarter ended Jun’16	Quarter ended Sep’16	Shareholding Pattern-27-10-2016
Quarter ended Dec’16	Quarter ended Mar’17	Quarter ended Jun’17
Quarter ended Sep’17	Quarter ended Dec’17	Quarter ended Mar’18
Quarter ended Jun’18	Quarter ended Sep’18	Quarter ended Dec’18
Quarter ended Mar’19	Quarter ended Jun’19	Quarter ended Sep’19
Quarter ended Dec’19	Quarter ended Mar’20	Quarter ended Mar’20 and Full Year 2020
Quarter ended Jun’20	Quarter ended Sep’20	Quarter ended Mar’21
Quarter ended Jun’21	Quarter ended Sep’21	Quarter ended Dec’21
Quarter ended Mar’22	Quarter ended Jun’22	Quarter ended Sep’22
Quarter ended Dec’22		<

Financial Results

Quarter ended Mar’11	Quarter ended Jun’11	Quarter ended Jun’12
Quarter ended Sep’11	Quarter Ended Sep’12	Quarter ended Dec’11
Quarter Ended Mar’12	Quarter Ended Dec’12	Quarter Ended Mar’13
Quarter Ended Jun’13	Quarter Ended Sep’13	Quarter Ended Dec’13
Quarter Ended Mar’14	Quarter Ended Jun’14	Quarter Ended Sep’14
Quarter Ended Dec’14	Quarter Ended Mar’15	Quarter Ended Jun’15
Quarter Ended Sep’15	Quarter Ended Dec’15	Quarter Ended Mar’16
Quarter Ended Jun’16	Quarter Ended Sep’16	Quarter Ended Dec’16
Quarter Ended Mar’17	Quarter Ended Jun’17	Quarter Ended Sep’17
Quarter Ended Dec’17	Quarter Ended Mar’18	Quarter Ended Jun’18
Quarter Ended Sep’18	Quarter Ended Dec’18	Quarter Ended Mar’19
Quarter Ended Jun’19	Quarter Ended Sep’19	Quarter Ended Dec’19
Quarter Ended Mar’20	Quarter Ended Jun’20	Quarter Ended Sep’20
Quarter Ended Dec’20	Quarter Ended Mar’21	Quarter Ended Jun’21
Quarter Ended Sep’21	Quarter Ended Dec’21	Quarter Ended Mar’22
Quarter Ended Jun’22	Quarter Ended Sep’22	Quarter Ended Dec’22

Corporate Governance Reports

Quarter ended Mar’11	Quarter ended Sep’11	Quarter ended Sep’11
Quarter ended Dec’11	Quarter ended Mar’12	Quarter ended Jun’12
Quarter ended Sep’12	Quarter ended Dec’12	Quarter ended Mar’13
Quarter ended June’13	Quarter ended Sep’13	Quarter ended Dec’13
Quarter ended Mar’14	Quarter ended Jun’14	Quarter ended Sep’14
Quarter Ended Dec’14	Quarter ended Mar’15	Quarter ended Jun’15
Quarter ended Sep’15	Quarter ended Dec’15	Quarter ended Mar’16
Quarter ended June’16	Quarter ended Sept’16	Quarter ended Dec’16
Quarter ended Mar’17	Quarter ended Jun’17	Quarter ended Sep’17
Quarter ended Dec’17	Quarter ended Mar’18	Quarter ended Jun’18
Quarter ended Sep’18	Quarter ended Dec’18	Quarter ended Mar’19
Quarter ended Jun’19	Quarter ended Sep’19	Quarter ended Dec’19
Quarter Ended Mar’20	Quarter Ended Jun’20	Quarter Ended Sep’20
Quarter ended Jun’20	Corporate Governance	Corporate Governance Mar’21
Quarter ended Jun’21	Quarter ended Sep’21	Quarter ended Dec’21
Quarter ended Mar’22	Quarter ended Jun’22	Quarter ended Sep’22
Quarter ended Dec’22

Company Policy

Corporate Social Responsibility Policy	Nomination and Remuneration Policy
Performance Evaluation of the Directors	Performance Evaluation of the Independent Directors
Policy on Related Party Transactions	Vigil Mechanism – Whistle Blower Policy
Archival Policy	Policy on Disclosure of Material Event
COMPOSITION OF COMMITTEES	Details of KMP for Determining Materiality of Events
Policy on Familiarisation Programme of Independent Directors	Dividend Distribution Policy

Familiarization Policy

2017-2018	2018-2019
2019-2020	2020-2021
2021-2022

Notice of Board Meeting

Notice of Board Meeting	Notice of Board Meeting 30/05/2016	Notice of Board Meeting 11/08/2016
Notice of Board Meeting-10-11-2016	Notice Regarding Board Meeting 27-10-2016	Notice of Board Meeting
Notice of Board Meeting held on 30.05.17	Notice for Financial Result for the Quarter Ended on June 30, 2017	Notice Regarding Board Meeting – 23-01-2018
Notice Regarding Board Meeting -30-05-2018	Notice Regarding Board Meeting -14-08-2018	Notice Regarding Board Meeting – 14-11-2018
Notice Regarding Board Meeting -12-02-2019	Notice Regarding Board Meeting -30-05-2019	Notice Regarding Board Meeting -14-08-2019
Notice Regarding Board Meeting -19-09-2019	Notice Regarding Board Meeting -14-11-2019	Notice Regarding Board Meeting – 13-02-2020
Notice Regarding Board Meeting – 27-02-2020	Notice Regarding Board Meeting – 25-06-2020	Notice Regarding Board Meeting – 20-08-2020
Notice regarding Board Meeting – 03-11-2020	Notice regarding Board Meeting – 02-02-2021	Notice regarding Board Meeting – 25-05-2021
Notice regarding Board Meeting – 10-08-2021	Notice regarding Board Meeting – 11-11-2021	Notice regarding Board Meeting – 10-02-2022
Notice regarding Board Meeting – 09-08-2022	Notice regarding Board Meeting – 10-11-2022	Notice Regarding Board Meeting 09-02-2023

Subsidiary Company Annual Reports

Zullinc Healthcare LLP-Annual Report- 2015-16	Lincoln Parenteral Limited-Annual Report- 2015-16
Zullinc Healthcare LLP-Annual Report- 2016-17	Lincoln Parenteral Limited-Annual Report- 2016-17
Lincoln Parenteral Limited-Annual Report- 2017-18	Zullinc Healthcare LLP- Annual Report 2017-2018
Savebux Finance & Investment Private Limited Annual Report 2017-18	Savebux Enterprise Pvt. Ltd. Annual Report 2018-19
Lincoln Parenteral Limited-Annual Report- 2018-19	Zullinc Healthcare LLP- Annual Report 2018-2019
Lincoln Parenteral Limited-Annual Report-2019-20
Annual Report 2019-2020	AGM-2020 Notice
AGM Transcript 2019-20
Notice – LPPL – 2020-21	Annual Report-LPPL-31-03-2021

Unpaid Dividend Data

FOR FINANCIAL YEAR 2014-2015	FOR FINANCIAL YEAR 2015-2016
FOR FINANCIAL YEAR 2016-2017	FOR FINANCIAL YEAR 2017-2018
FOR FINANCIAL YEAR 2018-2019	FOR FINANCIAL YEAR 2019-2020
FOR FINANCIAL YEAR 2020-2021

Business Presentation

LPL 2015-16 , Qtr.-1 Business Presentation	LPL 2015-16 , Qtr.-2 Business Presentation
LPL 2015-16 , Qtr.-3 Business Presentation	LPL 2015-16 , Qtr.-4 Business Presentation
LPL 2016-17 , Qtr.-1 Business Presentation	LPL 2016-17 , Qtr.-2 Business Presentation
LPL 2016-17 , Qtr.-3 Business Presentation	LPL 2016-17 , Qtr.-4 Business Presentation
LPL 2017-18 , Qtr.-1 Business Presentation	LPL 2017-18 , Qtr.-2 Business Presentation
LPL 2017-18 , Qtr.-3 Business Presentation	LPL 2017-18 , Qtr.-4 Business Presentation
LPL 2018-19 , Qtr.-1 Business Presentation	LPL 2018-19 , Qtr.-2 Business Presentation
LPL 2018-19 , Qtr.-3 Business Presentation	LPL 2018-19 , Qtr.-4 Business Presentation
LPL 2019-20 , Qtr.-1 Business Presentation	LPL 2019-20 , Qtr.-2 Business Presentation
LPL 2019-20 , Qtr.-3 Business Presentation	LPL 2019-20 , Qtr.-4 & Full year Business Presentation
LPL 2020-21 , Qtr.-1 Business Presentation	LPL 2020-21 , Qtr.-2 Business Presentation
LPL 2020-21 , Qtr.-3 Business Presentation	LPL 2020-21 , Qtr.-4 Business Presentation
LPL 2021-22 , Qtr.-1 Business Presentation	LPL 2021-22 , Qtr.-2 Business Presentation
LPL 2021-22 , Qtr.-3 Business Presentation	LPL 2021-22 , Qtr.-4 Business Presentation
LPL 2022-23 , Qtr.-1 Business Presentation	LPL 2022-23 , Qtr.-2 Business Presentation
LPL 2022-23 , Qtr.-3 Business Presentation

LPL IEPF Suspense Account

IEPF Suspense Account 2017	IEPF Suspense Account 2018
IEPF Suspense Account 2019	IEPF Suspense Account 2020
IEPF Suspense Account 2021	IEPF Suspense Account 2022

Scheme of Amalgamation

Prior Intimation to stock Exchange for Approve Draft Scheme of Ammalgamation	Outcome of Board Meeting of Scheme of Amalgamation
Audited Financials of Transferor & Transferee Cos.	Independent Auditor’s Certificate
Compliance Report	Draft Scheme of Amalgamation
Fairness Opinion by Merchant Banker	Shareholding Pattern of Transferor & Transferee Cos.
Report from the Audit Committee	Valuation Report from Independent Chartered Accountant
Complaint Report	Observation Letter from the Stock Exchanges
NCLT Order Dated Sept 17 2020	Notice to the Members of Lincoln Pharma-NCLT conveyed
Notice to the Members of Lincoln Parenteral-NCLT conveyed	Notice to the Secured Creditors of Lincoln Parenteral
Notice to the Un-Secured Creditors of Lincoln Parenteral	Voting Result & Scrutinizers’ Report of NCLT Meeting-Lincoln Pharmaceuticals Limited
Scrutinizers’ Report of NCLT Meeting of Un-Secured Creditors-Lincoln Parenteral Ltd	Scrutinizers’ Report of NCLT Meeting of Members-Lincoln Parenteral Ltd
Scrutinizers’ Report of NCLT Meeting of Secured Creditors-Lincoln Parenteral Ltd	Chairman Report of the Meeting of the Un-Secured Creditors of Lincoln Parenteral Limited
Chairman Report of the Meeting of the Secured Creditors of Lincoln Parenteral Limited	Chairman Report of the Meeting of the Equity Shareholders of Lincoln Pharmaceuticals Limited
Chairman Report of the Meeting of the Equity Shareholders of Lincoln Parenteral Limited	Order of NCLT on Scheme of Amalgamation

Credit Rating

Credit Rating 2020-21

Code of Conduct

Code of Conduct for Insiders Trading-LPL

Code of Conduct

Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information

Secretarial Compliance Report

Annual Secretarial Compliance Report 2020	Annual Secretarial Compliance Report 2021
Annual Secretarial Compliance Report 2022

TDS Communication

TDS Communication-2020-21-LPL

Related Party Transactions

RPT Lincoln Pharma 09-2021	RPT Lincoln Pharma 03-2022
RPT Lincoln Pharma 09-2022